Non-Antibody Products — page 33,313 of 44,716
Non-Antibody Products
Page 33,313 of 44,716
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| A-804598 | A-804598 is a potent and selective, competitive and high-affinity antagoni… | 50 mg | A-415 |
 ALOMONE LABS |
More Info |
| A-839977 | A-839977 is a potent and selective antagonist of P2X7 receptors, shown to… | 10 mg | A-470 |
ALOMONE LABS |
More Info |
| A-839977 | A-839977 is a potent and selective antagonist of P2X7 receptors, shown to… | 25 mg | A-470 |
ALOMONE LABS |
More Info |
| A-839977 | A-839977 is a potent and selective antagonist of P2X7 receptors, shown to… | 5 mg | A-470 |
ALOMONE LABS |
More Info |
| A-839977 | A-839977 is a potent and selective antagonist of P2X7 receptors, shown to… | 50 mg | A-470 |
ALOMONE LABS |
More Info |
| A-841720 | A-841720 is a potent and selective noncompetitive mGluR1 antagonist, actin… | 10 mg | A-440 |
ALOMONE LABS |
More Info |
| A-841720 | A-841720 is a potent and selective noncompetitive mGluR1 antagonist, actin… | 25 mg | A-440 |
ALOMONE LABS |
More Info |
| A-841720 | A-841720 is a potent and selective noncompetitive mGluR1 antagonist, actin… | 5 mg | A-440 |
ALOMONE LABS |
More Info |
| A-841720 | A-841720 is a potent and selective noncompetitive mGluR1 antagonist, actin… | 50 mg | A-440 |
ALOMONE LABS |
More Info |
| A-850002 | A-850002 inhibits mGluR1 in rat primary cerebellar granule neurons with an… | 10 mg | A-390 |
ALOMONE LABS |
More Info |
| A-850002 | A-850002 inhibits mGluR1 in rat primary cerebellar granule neurons with an… | 25 mg | A-390 |
ALOMONE LABS |
More Info |
| A-850002 | A-850002 inhibits mGluR1 in rat primary cerebellar granule neurons with an… | 5 mg | A-390 |
ALOMONE LABS |
More Info |
| A-850002 | A-850002 inhibits mGluR1 in rat primary cerebellar granule neurons with an… | 50 mg | A-390 |
ALOMONE LABS |
More Info |
| A-889425 | A-889425 blocks TRPV1 channels with an IC50 of 335 nM (rat) and 34 nM (hum… | 1 mg | A-195 |
ALOMONE LABS |
More Info |
| A-889425 | A-889425 blocks TRPV1 channels with an IC50 of 335 nM (rat) and 34 nM (hum… | 10 mg | A-195 |
ALOMONE LABS |
More Info |
| A-889425 | A-889425 blocks TRPV1 channels with an IC50 of 335 nM (rat) and 34 nM (hum… | 25 mg | A-195 |
ALOMONE LABS |
More Info |
| A-889425 | A-889425 blocks TRPV1 channels with an IC50 of 335 nM (rat) and 34 nM (hum… | 5 mg | A-195 |
ALOMONE LABS |
More Info |
| A-889425 | A-889425 blocks TRPV1 channels with an IC50 of 335 nM (rat) and 34 nM (hum… | 50 mg | A-195 |
ALOMONE LABS |
More Info |
| 293A | The HEK 293A cell line is an immortalized line of primary human embryonic… | 1 vial | ABI-TC1333 |
 ACCEGEN BIOTECH |
More Info |
| A10.7 | Derived from metastatic liver tumor (clinical stage IV). | 1 vial | ABC-TC533S |
ACCEGEN BIOTECH |
More Info |
| A-172 | Organ: brain Disease: glioblastoma. | 1 vial | ABC-TC0022 |
ACCEGEN BIOTECH |
More Info |
| A-204 | Human Muscle Rhabdomyosarcoma cell line. The A-204 cell line was establish… | 1 vial | ABC-TC445S |
ACCEGEN BIOTECH |
More Info |
| A2058 | Malignant melanoma, metastasis to lymph node. | 1 vial | ABC-TC0023 |
ACCEGEN BIOTECH |
More Info |
| A-253 | The A253 line is one of thirteen to be isolated and partially characterize… | 1 vial | ABC-TC0024 |
ACCEGEN BIOTECH |
More Info |
| A375 | This line was derived from a 54 year old female with malignant melanoma. | 1 vial | ABC-TC0026 |
ACCEGEN BIOTECH |
More Info |
| A-427 | A-427 cell line was established from the lung carcinoma of a 52-year-old C… | 1 vial | ABC-TC1339 |
ACCEGEN BIOTECH |
More Info |
| A-431 | The epidermoid carcinoma cell line A-431, derived from an 85-year-old fema… | 1 vial | ABC-TC0030 |
ACCEGEN BIOTECH |
More Info |
| A-498 | Established from the kidney carcinoma of a 52-year-old man in 1973. | 1 vial | ABC-TC0031 |
ACCEGEN BIOTECH |
More Info |
| A549 | A549 cell line was initiated in 1972 by D.J. Giard, et al. Through explant… | 1 vial | ABC-TC0032 |
ACCEGEN BIOTECH |
More Info |
| A6 | Frog (Xenopus laevis) cell line derived from kidney. Lifespan: infinite. | 1 vial | ABC-TC020S |
ACCEGEN BIOTECH |
More Info |
| A-673 | Tissue: muscle Disease: rhabdomyosarcoma. | 1 vial | ABC-TC0034 |
ACCEGEN BIOTECH |
More Info |
| A-704 | Human kidney adenocarcinoma. Derived from 78-year-old male. Does not produ… | 1 vial | ABC-TC0021 |
ACCEGEN BIOTECH |
More Info |
| A-72 | Canine Golden Retriever tumour. Derived from tumour of thigh (unknown hist… | 1 vial | ABC-TC0036 |
ACCEGEN BIOTECH |
More Info |
| A9 | Mouse C3H / An areolar and adipose tissue. Derivative of L929 selected in… | 1 vial | ABC-TC0037 |
ACCEGEN BIOTECH |
More Info |
| 10074-A4 | An inhibitor of the protein-protein interaction between c-Myc and Max; inh… | 1 mg | 37486-1 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| 10074-A4 | An inhibitor of the protein-protein interaction between c-Myc and Max; inh… | 10 mg | 37486-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 10074-A4 | An inhibitor of the protein-protein interaction between c-Myc and Max; inh… | 25 mg | 37486-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 10074-A4 | An inhibitor of the protein-protein interaction between c-Myc and Max; inh… | 5 mg | 37486-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 852A | A TLR7 agonist; selectively induces NF-κB signaling in HEK293 cells… | 1 mg | 39512-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 852A | A TLR7 agonist; selectively induces NF-κB signaling in HEK293 cells… | 10 mg | 39512-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 852A | A TLR7 agonist; selectively induces NF-κB signaling in HEK293 cells… | 25 mg | 39512-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| 852A | A TLR7 agonist; selectively induces NF-κB signaling in HEK293 cells… | 5 mg | 39512-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 1 mg | 9001799-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 10 mg | 9001799-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 25 mg | 9001799-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A 83-01 | An inhibitor of ALK5, ALK4, and ALK7 (IC50s = 12, 45, and 7.5 nM, respecti… | 5 mg | 9001799-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 10 mg | 26137-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 25 mg | 26137-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 5 mg | 26137-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| A01 | A Smurf1 inhibitor (Kd = 3.67 nM); inhibits Smurf1-mediated ubiquitination… | 50 mg | 26137-50 |
CAYMAN CHEMICAL COMPANY |
More Info |